Insight

A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.

Photo from dana-farber.org

Sep 20, 2023, 18:14

A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.

Quoting Dana-Farber News on X/Twitter:

“Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni Choueiri (Dana-Farber Lank Center for Genitourinary Oncology) identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing with deep learning.”

For details click here.

Source: Dana-Farber News/Twitter

cancer ccRCC Dana-Farber Cancer Institute Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber News Eli Van Allen Jackson Nyman OncoDaily Oncology Toni Choueiri

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC